PHASE 2 OPEN-LABEL EXTENSION (OLE) STUDY OF PATISIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAI) THERAPEUTIC FOR THE TREATMENT OF HEREDITARY ATTR AMYLOIDOSIS WITH POLYNEUROPATHY

David J. Adams,Teresa Coelho, E. Conceicao,Marcia Waddington-Cruz,Hartmut Schmidt,Juan Buades,Josep M. Campistol,Jean Pouget,John L. Berk,Michael Polydefkis, N. Ziyadeh,Angela M. Partisano,Jihong Chen,Jared Gollob,Ole B. Suhr

NEUROLOGY（2017）

引用 9|浏览29

暂无评分

摘要

PHASE 2 OPEN-LABEL EXTENSION (OLE) STUDY OF PATISIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAI) THERAPEUTIC FOR THE TREATMENT OF HEREDITARY ATTR AMYLOIDOSIS WITH POLYNEUROPATHY

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要